IFNL4 polymorphisms predict sustained response and HBsAg clearance in interferon treated HBeAg negative chronic hepatitis B patients. (15th February 2015) - Galmozzi, E.; Lampertico, P.; Facchetti, F.; Invernizzi, F.; Mangia, G.; Vigano, M.; Soffredini, R.; Colombo, M.